Cargando…

Synthesis and Preclinical Evaluation of Radiolabeled [(103)Ru]BOLD-100

The first-in-class ruthenium-based chemotherapeutic agent BOLD-100 (formerly IT-139, NKP-1339, KP1339) is currently the subject of clinical evaluation for the treatment of gastric, pancreatic, colorectal and bile duct cancer. A radiolabeled version of the compound could present a helpful diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Happl, Barbara, Brandt, Marie, Balber, Theresa, Benčurová, Katarína, Talip, Zeynep, Voegele, Alexander, Heffeter, Petra, Kandioller, Wolfgang, Van der Meulen, Nicholas P., Mitterhauser, Markus, Hacker, Marcus, Keppler, Bernhard K., Mindt, Thomas L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674160/ https://www.ncbi.nlm.nih.gov/pubmed/38004604 http://dx.doi.org/10.3390/pharmaceutics15112626

Ejemplares similares

Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of (99m)Tc-Tricarbonyl-Based Radiopharmaceuticals
por: Giammei, Carolina, et al.
Publicado: (2020)

CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging
por: Benčurová, Katarína, et al.
Publicado: (2022)

Experimental Nuclear Medicine Meets Tumor Biology
por: Balber, Theresa, et al.
Publicado: (2022)

Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines
por: Raitanen, Julia, et al.
Publicado: (2023)

Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation
por: Tosato, Marianna, et al.
Publicado: (2022)

In vitro Radiopharmaceutical Evidence for MCHR1 Binding Sites in Murine Brown Adipocytes
por: Balber, Theresa, et al.
Publicado: (2019)

Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
por: Joosten, Lieke, et al.
Publicado: (2017)

Evaluation of a Radiolabeled Macrocyclic Peptide as Potential PET Imaging Probe for PD−L1
por: Jouini, Nedra, et al.
Publicado: (2022)

The Radiolabeling of [161Tb]-PSMA-617 by a Novel Radiolabeling Method and Preclinical Evaluation by In Vitro/In Vivo Methods
por: UYGUR, EMRE, et al.
Publicado: (2023)

1,4-Disubstituted 1,2,3-Triazoles as Amide Bond Surrogates for the Stabilisation of Linear Peptides with Biological Activity
por: Rečnik, Lisa-Maria, et al.
Publicado: (2020)

Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme
por: Novy, Zbynek, et al.
Publicado: (2019)

Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh
por: Mastren, Tara, et al.
Publicado: (2017)

Preclinical In Vitro and In Vivo Evaluation of [(18)F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer
por: Balber, T., et al.
Publicado: (2018)

The Lipid Metabolism as Target and Modulator of BOLD‐100 Anticancer Activity: Crosstalk with Histone Acetylation
por: Baier, Dina, et al.
Publicado: (2023)

The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo—A Comparison of O,O‐, S,O‐, and N,N‐Chelate Effects
por: Berasaluce, Iker, et al.
Publicado: (2019)

Synthesis, Modification, and Biological Evaluation of a Library of Novel Water‐Soluble Thiopyridone‐Based Organometallic Complexes and Their Unexpected (Biological) Behavior
por: Harringer, Sophia, et al.
Publicado: (2020)

The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation
por: Baier, Dina, et al.
Publicado: (2022)

Radiolabeled NGR-Based Heterodimers for Angiogenesis Imaging: A Review of Preclinical Studies
por: Trencsényi, György, et al.
Publicado: (2023)

Preclinical evaluation of carbon-11 and fluorine-18 sulfonamide derivatives for in vivo radiolabeling of erythrocytes
por: Gheysens, Olivier, et al.
Publicado: (2013)

State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET
por: Chomet, Marion, et al.
Publicado: (2021)

Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials
por: Fazekas-Singer, Judit, et al.
Publicado: (2017)

Use of radiolabeled hyaluronic acid for preclinical assessment of inflammatory injury and acute respiratory distress syndrome
por: Zhao, Fangyuan, et al.
Publicado: (2022)

Targeted Tumor Therapy with Radiolabeled DNA Intercalator: A Possibility? Preclinical Investigations with (177)Lu-Acridine
por: Ghosh, Subhajit, et al.
Publicado: (2020)

Solvolysis of the Tumor-Inhibiting Ru(III)-Complex trans-Tetrachlorobis(Indazole)Ruthenate(III)
por: Pieper, Thomas, et al.
Publicado: (2000)

A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with (68)Ga, (44)Sc, (177)Lu and (161)Tb
por: Talip, Zeynep, et al.
Publicado: (2020)

SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [(18)F]FE@SNAP and [(11)C]SNAP-7941
por: Philippe, Cécile, et al.
Publicado: (2018)

Radiolabeled Bombesin Analogs
por: Mansi, Rosalba, et al.
Publicado: (2021)

Radiolabeled PSMA Inhibitors
por: Neels, Oliver C., et al.
Publicado: (2021)

Pharmacokinetic evaluation of radiolabeled intraocular anti‐CLEC14a antibody in preclinical animal species and application in humans
por: Park, Sohyun, et al.
Publicado: (2022)

Preclinical evaluation of (68)Ga-radiolabeled trimeric affibody for PDGFRβ-targeting PET imaging of hepatocellular carcinoma
por: Cai, Huawei, et al.
Publicado: (2023)

Bold conceptions
Publicado: (1998)

Selling Boldly
por: Goldfayn, Alex
Publicado: (2018)

The London Is Bold
Publicado: (1890)

If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[(18)F]FDG Metabolism
por: Klebermass, Eva-Maria, et al.
Publicado: (2021)

A fingerprint of 2-[(18)F]FDG radiometabolites – How tissue-specific metabolism beyond 2-[(18)F]FDG-6-P could affect tracer accumulation
por: Patronas, Eva-Maria, et al.
Publicado: (2023)

Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [(11)C]ME@HAPTHI
por: Rami-Mark, Christina, et al.
Publicado: (2015)

The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer
por: Vigolo, Michele, et al.
Publicado: (2023)

Symphony No. 103/
por: Haydn, Joseph

Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin
por: Kratz, F., et al.
Publicado: (1994)

Radiolabeling and Preclinical Evaluation of a New S-Alkylated Cysteine Derivative Conjugated to C-Substituted Macrocycle for Positron Emission Tomography
por: Prakash, Surbhi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k6lkg10oj3vn295jqsvob3gfd9